Work

Daratumumab Activity Is Agnostic to Fc Gamma Receptor 3A (FcγR3A) 158 Genotype in Patients with Primary Refractory or Relapsed Systemic AL Amyloidosis

Year: 2017

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.3164.3164

Authors: Lisa Xingguang Lee, Katelynn Ho, Ping Zhou, Cindy Varga, Teresa Fogaren, Denis Toskic, Adin Kugelmass, Raymond L. Comenzo

Institutions: Tufts Medical Center, Tufts University

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3081935729

FWCI:

Cites:

Cited by: 1

Related to: 10